CASI Pharmaceuticals CASIF
OTC CASIF
$0.13 +0.00 (+0.00%)
As of: Aug 21, 2026 · 9:30 AM EDT

CASI Pharmaceuticals (CASIF) Property, Plant & Equipment (Net) (2021 - 2025)

CASI Pharmaceuticals (CASIF) Property, Plant & Equipment (Net) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 CASI Pharmaceuticals 2.65 Mn -3.76 Bn - 6.57 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.97 Mn
Dec 31, 2025 6.97 Mn
Sep 30, 2025 7.14 Mn
Sep 30, 2025 7.14 Mn
Jun 30, 2025 7.40 Mn
Jun 30, 2025 7.40 Mn
Mar 31, 2025 7.66 Bn
Mar 31, 2025 7.66 Bn
Dec 31, 2024 7.87 Mn
Dec 31, 2024 7.87 Mn
Jun 30, 2024 8.50 Bn
Jun 30, 2024 8.50 Bn
Mar 31, 2024 8.79 Mn
Mar 31, 2024 8.79 Mn
Dec 31, 2023 9.24 Bn
Dec 31, 2023 9.24 Bn
Jun 30, 2023 10.12 Bn
Jun 30, 2023 10.12 Bn
Dec 31, 2022 11.83 Mn
Dec 31, 2022 11.83 Mn